The issue of the acceptance of the Covishield vaccine as proof of immunisation for travel to the EU Member States has been widely discussed recently, after several countries in the block have refused to recognise the vaccine.
We are quite confident that in a month EMA will approve Covishield. There is no reason why not to, because it is based on AstraZeneca data and our product is identical to AstraZeneca more or less and it has been approved by WHO, UK MHRA, Adar Poonawalla said.
Covishield is the Oxford University-AstraZeneca vaccine manufactured in India by the Pune-based vaccine maker.
Serum Institute of India (SII) CEO Adar Poonawalla has thanked US President Joe Biden, External Affairs Minister S Jaishankar for policy change with respect to raw material needed for vaccine production saying it will boost manufacturing and strengthen fight against Covid.
India has so far not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects.
There are many parts of the world where one shot has been dispensed to health workers or frontline workers and the second shot has not been forthcoming, USAID told lawmakers on Thursday.
Serum Institute of India (SII) CEO Adar Poonawalla said that vaccination in a large populous country such as India won't be possible in 2-3 months.
WHO chief Tedros Adhanom Ghebreyesus has said that once the devastating COVID-19 outbreak in India recedes, the Serum Institute of India will need to “get back on track and catch up” on its delivery commitments to COVAX, the global initiative to supply coronavirus vaccines to nations around the world.
The Maharashtra state cabinet held a meeting on Wednesday to discuss the Covid management.
Maharashtra Health Minister Rajesh Tope on Monday urged Serum Institute of India Chief Executive Officer Adar Poonawalla to give priority to the state in providing its anti-coronavirus vaccine as the government was ready to purchase doses from the Pune-based company.
Serum Institute of India (SII) CEO Adar Poonawalla has issued a statement regarding vaccine availability in the country and ramping up its production. SII issued Poonawalla's statement after some of his comments on vaccine production were misinterpreted.
Serum Institute of India CEO Aadar Poonawalla has said that the production of COVID-19 vaccine Covishield is in full swing in Pune and he will review the operations once he is back in the country.
According to the Home ministry's order, Poonawalla will be provided security by the Central Reserve Police Force (CRPF) wherever he travels in India.
Serum Institute of India's CEO Adar Poonawalla on on Wednesday tweeted that the revised price will be effective immediately.
The Serum Institute of India (SII) on Saturday said only a limited portion of its vaccines volume will be sold to private hospitals at Rs 600 per dose.
Gorakhpur MLA Dr Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state govts.
Serum Institute of India (SII) CEO Adar Poonawalla has urged US President Joe Biden to lift the embargo of raw material exports for the vaccine industry outside the United States so that the vaccine production can ramp up.
Poonawalla has mentioned that the existing production capacity to manufacture Covishield in India is under pressure due to increased demand in India.
India has already provided over 229 lakh doses of coronavirus vaccines to various countries out of which 64 lakh doses have been supplied as grant assistance and 165 lakh on commercial basis.
Cyrus Poonawalla was born in a family that had old ties to India racing circuit, through the family Poonawalla Stud Farms. At a young age, Poonawalla realized that since the horse racing had no future in a socialist nation like India, he needed to explore other venues. He realized that creating a product for the masses than for the elite would be a smarter move. The Serum Institute of India was founded by the Poonawalla in 1966, and they launched their first therapeutic tetanus serum within two years and started producing the anti-tetanus vaccines soon after.
Top News
Latest News
